Get the Weekly Intelligence Brief — top committee picks every Sunday.
GEHC · NASDAQ · STOCK

GE HealthCare (GEHC) Stock Analysis

Healthcare Updated October 10, 2026
$65.75
52W $58.75 – $89.77
58/100
$29.69B
18.9
0.85
AI Committee Verdict
Buy
58/100
Conviction: Moderate · 60% agreement · 5 analysts
+15.0%
-2.9%
5.09:1
Moderate

Is GEHC Bullish or Bearish?

Bullish. Innellis AI committee rates GE HealthCare (GEHC) Buy with a composite score of 58/100 , based on 5 analysts with 60% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +16.67 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -3.33 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Value Analyst sees a compelling case — p/e of 15.0 is inexpensive for the broad market. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • P/E of 15.0 is inexpensive for the broad market — Value
  • ROE of 18.9% shows genuine earnings power backing the valuation — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • EPS declining -11.0% YoY despite any revenue growth — Growth
  • Price structure making lower highs and lower lows — Technical
  • Price structure (HH_HL) contradicts the downtrend -- mixed signals — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
58/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 43%
of 192 Healthcare peers
Value Analyst bullish
70 / 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ P/E of 15.0 is inexpensive for the broad market
Growth Analyst neutral
48 / 100 · High confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− EPS declining -11.0% YoY despite any revenue growth
Technical Analyst neutral
53 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
55 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 58.3 to 58.3.

Analyst-level changes:
  • Value Analyst: +1 bullish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
54.0
Neutral
MACD Histogram
0.129
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Hh Hl
Support
$63.81
Resistance
$75.59
Bollinger %B
0.65
Inside Bands
Price vs Moving Averages
EMA 9
$65.13 Above
EMA 21
$65.76 Below
EMA 50
$66.77 Below
EMA 200
$69.59 Below

Fundamental Analysis

Valuation
89
Growth
63
Profitability
63
Financial Health
49
Cash Flow
70
Valuation
P/E Ratio 18.9×
P/B Ratio 2.71×
PEG Ratio -0.65
Dividend Yield 0.21%
52W High $89.77
52W Low $58.75
Quality & Growth
ROE 2007.9%
ROA 564.7%
Gross Margin 4290.4%
Operating Margin 1270.1%
Revenue Growth YoY —
Debt / Equity 0.92
AI Fundamental Assessment
P/E ratio of 18.9 (inexpensive relative to a 15-40x range); Price-to-book of 2.7x; PEG ratio of -0.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 20.1%; Return on assets of 5.6%; Net margin of 7.9%; Gross margin of 42.9%; Current ratio of 1.02 (tight short-term liquidity); Debt-to-equity of 0.92; Free cash flow per share is positive (1.98); Most recent quarter beat estimates by 7.0%; EPS growth accelerating (-31.2% -> +14.1% QoQ); Average YoY EPS growth of 6.6%; Analyst estimates falling over recent quarters
Get the Full GEHC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime